M.S. Kang

1.1k total citations
20 papers, 736 citations indexed

About

M.S. Kang is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M.S. Kang has authored 20 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M.S. Kang's work include Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). M.S. Kang is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). M.S. Kang collaborates with scholars based in United States, United Kingdom and China. M.S. Kang's co-authors include E Cabib, Alan D. Elbein, Janice Au-Young, Paul J. Szaniszlo, D.L. Taylor, A.S. Tyms, N. Elango, Elena Di Mattia, Phillips W. Robbins and Prasad S. Sunkara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

M.S. Kang

20 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.S. Kang United States 14 463 234 196 118 107 20 736
Irena Pastuszak United States 18 638 1.4× 131 0.6× 400 2.0× 75 0.6× 223 2.1× 26 925
D.E. Blair United Kingdom 11 658 1.4× 130 0.6× 310 1.6× 163 1.4× 166 1.6× 11 825
Thomas S. Stewart Australia 16 492 1.1× 125 0.5× 88 0.4× 91 0.8× 123 1.1× 24 737
Wouter Vervecken Belgium 13 685 1.5× 110 0.5× 137 0.7× 153 1.3× 226 2.1× 19 886
Grażyna Palamarczyk Poland 19 966 2.1× 207 0.9× 181 0.9× 40 0.3× 172 1.6× 62 1.1k
Johannes F.G. Vliegenthart Netherlands 16 428 0.9× 232 1.0× 231 1.2× 85 0.7× 130 1.2× 20 883
W. T. Forsee United States 19 685 1.5× 159 0.7× 475 2.4× 88 0.7× 132 1.2× 39 977
Bjørn Spilsberg Norway 17 551 1.2× 190 0.8× 276 1.4× 194 1.6× 90 0.8× 38 1.1k
Shi Yan Austria 18 588 1.3× 151 0.6× 198 1.0× 184 1.6× 70 0.7× 49 910
Susan K. Boehlein United States 21 603 1.3× 414 1.8× 74 0.4× 35 0.3× 172 1.6× 50 1.2k

Countries citing papers authored by M.S. Kang

Since Specialization
Citations

This map shows the geographic impact of M.S. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.S. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.S. Kang more than expected).

Fields of papers citing papers by M.S. Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.S. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.S. Kang. The network helps show where M.S. Kang may publish in the future.

Co-authorship network of co-authors of M.S. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of M.S. Kang. A scholar is included among the top collaborators of M.S. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.S. Kang. M.S. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Chao, et al.. (2025). Baicalin: Natural Sources, Extraction Techniques, and Therapeutic Applications Against Bacterial Infections. Molecules. 30(17). 3464–3464. 2 indexed citations
2.
Wang, Zening, M.S. Kang, Afshin Ebrahimpour, Chuan Chen, & Xin Ge. (2024). Fc engineering by monoclonal mammalian cell display for improved affinity and selectivity towards FcγRs. PubMed. 7(3). 209–220. 2 indexed citations
3.
Kang, M.S., Zening Wang, & Xin Ge. (2023). One‐step production of fully biotinylated and glycosylated human Fc gamma receptors. Biotechnology Progress. 40(1). e3392–e3392. 3 indexed citations
4.
Chen, Chuan, Zening Wang, M.S. Kang, Ki Baek Lee, & Xin Ge. (2023). High-fidelity large-diversity monoclonal mammalian cell libraries by cell cycle arrested recombinase-mediated cassette exchange. Nucleic Acids Research. 51(22). e113–e113. 5 indexed citations
5.
Kang, M.S., et al.. (2003). Establishment and characterization of two new cell lines derived from flounder, Paralichthys olivaceus (Temminck & Schlegel). Journal of Fish Diseases. 26(11-12). 657–665. 72 indexed citations
8.
Taylor, D.L., Robert J. Nash, Linda E. Fellows, M.S. Kang, & A.S. Tyms. (1992). Naturally Occurring Pyrrolizidines: Inhibition of α-Glucosidase 1 and Anti-HIV Activity of One Stereoisomer. Antiviral chemistry & chemotherapy. 3(5). 273–277. 49 indexed citations
9.
Bowlin, Terry L., et al.. (1989). Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing.. PubMed. 49(15). 4109–13. 33 indexed citations
10.
Kang, M.S. & E Cabib. (1986). Regulation of fungal cell wall growth: a guanine nucleotide-binding, proteinaceous component required for activity of (1----3)-beta-D-glucan synthase.. Proceedings of the National Academy of Sciences. 83(16). 5808–5812. 91 indexed citations
11.
Kang, M.S., Janice Au-Young, & E Cabib. (1985). Modification of yeast plasma membrane density by concanavalin A attachment. Application to study of chitin synthetase distribution.. Journal of Biological Chemistry. 260(23). 12680–12684. 17 indexed citations
12.
Szaniszlo, Paul J., M.S. Kang, & E Cabib. (1985). Stimulation of beta(1----3)glucan synthetase of various fungi by nucleoside triphosphates: generalized regulatory mechanism for cell wall biosynthesis. Journal of Bacteriology. 161(3). 1188–1194. 61 indexed citations
13.
Kang, M.S., N. Elango, Elena Di Mattia, et al.. (1984). Isolation of chitin synthetase from Saccharomyces cerevisiae. Purification of an enzyme by entrapment in the reaction product.. Journal of Biological Chemistry. 259(23). 14966–14972. 113 indexed citations
14.
Kang, M.S. & Alan D. Elbein. (1983). Alterations in the Structure of the Oligosaccharide of Vesicular Stomatitis Virus G Protein by Swainsonine. Journal of Virology. 46(1). 60–69. 61 indexed citations
15.
Kang, M.S., et al.. (1981). Streptovirudin inhibits glycosylation and multiplication of vesicular stomatitis virus. Biochemical and Biophysical Research Communications. 99(2). 422–428. 1 indexed citations
16.
Elbein, Alan D., John T. Gafford, & M.S. Kang. (1979). Inhibition of lipid-linked saccharide synthesis: Comparison of tunicamycin, streptovirudin, and antibiotic 24010. Archives of Biochemistry and Biophysics. 196(1). 311–318. 39 indexed citations
17.
Kang, M.S., et al.. (1979). The effect of showdomycin on glycolipid formation. Inhibition of glucosyl-phosphoryl-dolichol in aorta and stimulation of glucosylceramide in yeast.. Journal of Biological Chemistry. 254(20). 10037–10043. 18 indexed citations
18.
Kang, M.S., et al.. (1978). Amphomycin inhibits the incorporation of mannose and GlcNAc into lipid-linked saccharides by aorta extracts. Biochemical and Biophysical Research Communications. 82(2). 568–574. 19 indexed citations
19.
Kang, M.S., et al.. (1978). Inhibition of lipid-linked saccharide synthesis by bacitracin. Archives of Biochemistry and Biophysics. 190(2). 829–837. 19 indexed citations
20.
Kang, M.S., et al.. (1978). Amphomycin inhibition of mannose and GlcNAc incorporation into lipid-linked saccharides.. Journal of Biological Chemistry. 253(24). 8860–8866. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026